Empagliflozin and Metformin Tablet
|
Generic Name |
Empagliflozin and Metformin |
|---|---|
|
Strength |
12.5 mg + 500 mg |
|
Form |
Tablet |
|
Packaging |
1 X 10 Tablets |
|
Therapeutic use |
Anti Diabetic |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Voglibose and Metformin Tablet | 0.2 mg + 1000 mg, 0.2 mg + 500 mg, 0.3mg + 1000 mg, 0.3 mg + 500 mg | Anti Diabetic | |
| Glimepiride, Pioglitazone and Metformin Tablet | 2 mg + 500 mg + 7.5 mg, 1 mg + 500 mg + 15mg, 2 mg + 500 mg + 15 mg | Anti Diabetic | |
| Glimepiride, Metformin and Voglibose Tablet | 1 mg + 500 mg + 0.2 mg, 2 mg + 500 mg + 0.2 mg | Anti Diabetic | |
| Gliclazide and Metformin Tablet | 60 mg + 500 mg, 80 mg + 500 mg | Anti Diabetic | |
| Glibenclamide and Metformin Tablet | 2.5 mg + 500 mg, 5 mg + 500 mg | Anti Diabetic | |
| Empagliflozin Tablet | 10 mg, 25 mg | Anti Diabetic | |
| Empagliflozin and Metformin Tablet | 12.5 mg + 500 mg | Anti Diabetic | |
| Pioglitazone and Metformin HCL Tablet | 15 mg + 500 mg | Anti Diabetic, Type 2 diabetes | |
| Sitagliptin and Metformin Tablet | 50 mg + 1000 mg, 50 mg + 500 mg | Anti Diabetic, Type 2 diabetes |
Product Description For Empagliflozin and Metformin Tablet
products details and uses
Empagliflozin and Metformin Tablet Exporter India, Manufacturer and Global Supplier
Empagliflozin and Metformin Tablet Exporter India, with the growing demand for advanced diabetes care, the role of a reliable is crucial in making this innovative therapy available across global markets. Empagliflozin and Metformin Tablet is a widely prescribed oral antidiabetic medicine formulated for effective management of Type 2 Diabetes Mellitus. This combination brings together two active agents—Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin, a biguanide antidiabetic agent. Together, they work synergistically to improve glycemic control in adults by lowering blood sugar levels, reducing insulin resistance, and promoting glucose excretion through the urine.
Key Benefits and Uses
-
Blood Sugar Regulation – Empagliflozin reduces glucose reabsorption from the kidneys, while Metformin lowers glucose production in the liver and enhances insulin sensitivity.
-
Weight Management – Many patients benefit from modest weight reduction due to the SGLT2 inhibitor effect of Empagliflozin.
-
Cardiovascular Protection – Clinical studies suggest that Empagliflozin may lower the risk of cardiovascular death in patients with Type 2 Diabetes and established heart disease.
-
Long-Term Diabetes Care – The dual action makes this tablet effective for sustained glycemic control when diet and exercise alone are insufficient.
Global pharmaceutical distributors and healthcare providers rely on a trusted Empagliflozin and Metformin Tablet Exporter India to ensure access to high-quality, affordable formulations that meet international regulatory standards.
Precautions
-
Kidney Function: Regular monitoring of renal function is necessary, as both components are excreted through the kidneys.
-
Liver Impairment: Patients with severe liver disease should use with caution.
-
Hydration: Adequate fluid intake is recommended to minimize dehydration risk from increased urination caused by Empagliflozin.
-
Medical History: Inform the physician about heart disease, urinary tract infections, or ketoacidosis before starting therapy.
-
Pregnancy and Breastfeeding: Not generally recommended without medical supervision due to limited safety data.
Pharmaceutical companies ensure that every batch exported by a certified Empagliflozin and Metformin Tablet Exporter India adheres to Good Manufacturing Practices (GMP) and WHO guidelines to maintain safety and efficacy standards.
Possible Side Effects
Like all medications, Empagliflozin and Metformin Tablet may cause some side effects. These are usually mild and manageable but should be discussed with a healthcare provider.
-
Common Side Effects: Nausea, diarrhea, headache, increased urination, and low blood sugar (when combined with insulin or sulfonylureas).
-
Serious Side Effects: Lactic acidosis (rare but serious complication of Metformin), genital infections, dehydration, and electrolyte imbalance.
Patients should immediately report severe abdominal pain, unusual tiredness, or symptoms of infection. Exporters ensure that product packaging carries proper safety labeling to guide patients and healthcare providers.
Why Choose a Trusted Empagliflozin and Metformin Tablet Exporter India?
India has established itself as a global hub for pharmaceutical manufacturing and supply. A reputable Empagliflozin and Metformin Tablet Exporter India offers:
-
Consistent quality with strict adherence to pharmacopeia standards.
-
Affordable pricing compared to global markets.
-
Customized packaging to meet international import regulations.
-
Timely logistics and supply chain support for uninterrupted availability.
By partnering with a reliable supplier, healthcare distributors and hospitals worldwide can secure uninterrupted access to safe and effective diabetes medications.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Empagliflozin and Metformin Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.